Jiangsu Huafeng Ruixun Biomaterials Co., Ltd. is a wholly-owned subsidiary of Huafeng Group, a Fortune China 500 enterprise. It mainly produces bio-based PTMEG. This technology was developed and pilot-tested by DuPont of the United States. Huafeng Group acquired DuPont's bio-based segment in 2022 and established Covation Biomaterials LLC in 2022. The company is located in Newark, Delaware. It is a company with advanced innovative technologies in the field of bio-based materials, focusing on a product portfolio of high-performance and sustainable solutions. The company inherits DuPont's pioneering tradition of scientific innovation and provides innovative solutions for multiple industries such as apparel, carpets, cosmetics, food, and packaging.
Huafeng Group is committed to building Jiangsu Huafeng Ruixun into a high-tech, new-type, cutting-edge enterprise, inheriting DuPont's safety philosophy and management model, moving toward internationalized management, and transforming toward green and sustainable development.
The project announcement information is as follows:
In September 2024, Jiangsu Huafeng Ruixun Biomaterials Co., Ltd. announced the project with an annual output of 500,000 tons of bio-based polytetramethylene ether glycol (BioPTMEG), 20,000 tons of tetrahydrofuran, and by-products of 45,500 tons of methyl acetate, 3,500 tons of 1,4-butanediol, and 1,500 tons of gamma-butyrolactone.
Project name: Annual output of 500,000 tons of bio-based polytetramethylene ether glycol (BioPTMEG), 20,000 tons of tetrahydrofuran, and by-products of 45,500 tons of methyl acetate, 3,500 tons of 1,4-butanediol, and 1,500 tons of gamma-butyrolactone project;
Project nature: New construction
Industry category: The natural gas-to-hydrogen production of this project belongs to C2619 Manufacture of Other Basic Chemical Raw Materials; the production of tetrahydrofuran, butanediol, butyrolactone, and methyl acetate belongs to C2614 Manufacture of Organic Chemical Raw Materials; PTMEG production belongs to C2832 Manufacture of Bio-based and Starch-based New Materials;
Construction unit: Jiangsu Huafeng Ruixun Biomaterials Co., Ltd.;
Construction location: Weiba Road, Tongzhou Bay Green Chemical Expansion Zone (Lüsigang), Qidong City, Nantong City, Jiangsu Province;
Total investment: The total investment is approximately 10.07797 billion yuan, including 151.10 million yuan for environmental protection investment;
Construction timeline: Phase I project is expected to be completed and put into operation around 2026, Phase II around 2028, and Phase III around 2030.
This project uses furfural produced from corncobs as the main raw material and annually produces 500,000 tons of bio-based polytetramethylene ether glycol (BioPTMEG), 20,000 tons of tetrahydrofuran, and by-products of 45,500 tons of methyl acetate, 3,500 tons of 1,4-butanediol, and 1,500 tons of gamma-butyrolactone.
The project is planned to be constructed in three phases, including Phase I PTMEG capacity of 50,000 t/a, Phase II PTMEG capacity of 150,000 t/a, and Phase III PTMEG capacity of 300,000 t/a; the capacity of other products is matched accordingly.
What does Jiangsu Huafeng Ruixun Biomaterials Co., Ltd. require? Who is Jiangsu Huafeng Ruixun Biomaterials Co., Ltd. hiring? recruitment: 技工类占比最多占68.2%,其次是机械/仪器仪表类占36.4%. What education can get in at ? 大专占比最多占77.3%,其次是高中占18.2%. Work experience required at ? 不限占比最多占81.8%,其次是1-3年占18.2%. Where are the job locations at ? 南通占比最多占95.5%,其次是上海占4.5%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows